Sputnik V

  • Russian scientist behind COVID-19 vaccine defends 'wartime' roll-out
    MOSCOW, September 29 (Reuters): Russia plans to share preliminary results of its COVID-19 vaccine trial based on the first six weeks of monitoring participants, raising the tempo in an already frenzied global race to end the pandemic. Alexander Gintsburg, head of the Gamaleya Institute that produced the Sputnik V vaccine, told Reuters that the pace of its development was necessary under the "wartime" conditions of a pandemic but no corners were being cut. Russia ha
  • Russia to begin COVID-19 vaccine trials on 40,000 people next week
    MOSCOW, August 20 (Reuters): Mass testing of Russia's first potential COVID-19 vaccine to get domestic regulatory approval will involve more than 40,000 people and will be overseen by a foreign research body when it starts next week, backers of the project said on Thursday. These were the first details on the shape and size of the upcoming late-stage trial of the vaccine given by its developers, who are aiming to allay concerns among some scientists about the lack of data p
  • Russian doctors wary of rapidly approved COVID-19 vaccine, survey shows
    MOSCOW, August 14 (Reuters): A majority of Russian doctors would not feel comfortable being injected with Russia's new COVID-19 vaccine due to the lack of sufficient data about it and its super-fast approval, a survey of more than 3,000 medical professionals showed on Friday. Russia has said that the world's first vaccine for the novel coronavirus will be rolled out by the end of this month, with doctors among those set to be administered with it on a voluntary basis.
  • Russia names new COVID-19 vaccine 'Sputnik V' in reference to Cold War space race
    MOSCOW, August 11 (Reuters): Russia has named its first approved COVID-19 vaccine 'Sputnik V' for foreign markets, a reference to the world's first satellite and what Moscow sees as its success at becoming the first country to approve a vaccine, a top official said on Tuesday. Kirill Dmitriev, head of the country's RDIF sovereign wealth fund, said Russia had already received requests from more than 20 countries for 1 billion doses of its newly-registered COVID-1